People who quit taking anti-obesity meds, including popular GLP-1 receptor agonists, may regain a significant amount of weight after eight weeks, a new study finds.

A new study finds the combination of excess weight and heart disease in postmenopausal women is associated with an especially high risk of developing breast cancer.

A new study finds diet quality and waist-to-hip ratio strongly impact brain function as you age.

An international group of medical experts says body mass index is not a reliable way to diagnose obesity. Members of the Commission on Clinical Obesity are recommending new methods that also consider location of excess body fat and objective symptoms of disease.

A new study finds using GLP-1 receptor agonists to treat obesity in otherwise healthy adults is safe and very effective.

New study examines U.S. trends in body mass index and obesity and finds improving numbers, driven in part by GLP-1 weight-loss drugs.

Researchers are now testing a new semaglutide delivery platform that combines the medication with a special hydrogel to achieve sustained release over one month or longer.

A new study finds overweight people who stay awake too late face higher odds of metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke and diabetes.